C R Alving
Overview
Explore the profile of C R Alving including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
1952
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Friedman R, Iglewski B, Roerdink F, Alving C
Biophys J
. 2009 May;
37(1):23-4.
PMID: 19431480
No abstract available.
2.
Glenn G, Scharton-Kersten T, Alving C
Expert Opin Investig Drugs
. 2005 Jul;
8(6):797-805.
PMID: 15992132
Needle-free delivery of vaccines has become a global priority. Transcutaneous immunisation (TCI), topical application of vaccine antigens to the skin, can elicit systemic antibody and T-cell responses, suggesting that this...
3.
Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique N, Alving C, et al.
Ann Oncol
. 2003 Sep;
14(9):1430-7.
PMID: 12954584
Background: Pegylated liposomal doxorubicin (Doxil) has been reported to cause immediate hypersensitivity reactions (HSRs) that cannot be explained as IgE-mediated (type I) allergy. Previous in vitro and animal studies indicated...
4.
Szebeni J, Baranyi L, Savay S, Milosevits J, Bunger R, Laverman P, et al.
J Liposome Res
. 2003 Feb;
12(1-2):165-72.
PMID: 12604051
Pegylated liposomal doxorubicin (Doxil) and 99mTc-HYNIC PEG liposomes (HPL) were reported earlier to cause hypersensitivity reactions (HSRs) in a substantial percentage of patients treated i.v. with these formulations. Here we...
5.
Szebeni J, Alving C, Savay S, Barenholz Y, Priev A, Danino D, et al.
Int Immunopharmacol
. 2001 May;
1(4):721-35.
PMID: 11357884
We reported earlier that the anticancer drug paclitaxel (Taxol) activated the complement (C) system in human serum in vitro, raising the possibility that C activation might play a role in...
6.
Hammond S, Walwender D, Alving C, Glenn G
Vaccine
. 2001 Mar;
19(17-19):2701-7.
PMID: 11257412
Transcutaneous immunization (TCI) is a novel immunization strategy by which antigen and adjuvant are applied topically to intact, hydrated skin to induce potent antibody and cell-mediated immune responses specific for...
7.
Glenn G, Taylor D, Li X, Frankel S, Montemarano A, Alving C
Nat Med
. 2000 Dec;
6(12):1403-6.
PMID: 11100128
Transcutaneous immunization, a topical vaccine application, combines the advantages of needle-free delivery while targeting the immunologically rich milieu of the skin. In animal studies, this simple technique induces robust systemic...
8.
Matyas G, Wassef N, Rao M, Alving C
J Immunol Methods
. 2000 Oct;
245(1-2):1-14.
PMID: 11042279
An enzyme-linked immunosorbent assay (ELISA) utilizing antigen coated on hydrophobic polyvinyldiene fluoride (PVDF) membranes is described for detecting antibodies that bind to squalene (SQE). Because of the prior lack of...
9.
Rothwell S, Wassef N, Alving C, Rao M
Immunol Lett
. 2000 Sep;
74(2):141-52.
PMID: 10996390
Liposome-encapsulated conalbumin (L(conalbumin)) is an antigen that is efficiently phagocytosed by bone marrow-derived macrophages and presented to effector cells as part of the major histocompatibility complex (MHC) class I complex....
10.
Szebeni J, Baranyi L, Savay S, Bodo M, Morse D, Basta M, et al.
Am J Physiol Heart Circ Physiol
. 2000 Sep;
279(3):H1319-28.
PMID: 10993799
Intravenous injection of liposomes can cause significant pulmonary hypertension in pigs, a vasoconstrictive response that provides a sensitive model for the cardiopulmonary distress in humans caused by some liposomal drugs....